73 related articles for article (PubMed ID: 27610459)
1. Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population.
Lee MK; Cheong HS; Koh Y; Ahn KS; Yoon SS; Shin HD
Genet Test Mol Biomarkers; 2016 Nov; 20(11):696-701. PubMed ID: 27610459
[TBL] [Abstract][Full Text] [Related]
2. SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
Kim JH; Lee C; Cheong HS; Koh Y; Ahn KS; Kim HL; Shin HD; Yoon SS
Cancer Chemother Pharmacol; 2016 Sep; 78(3):533-40. PubMed ID: 27422302
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population.
Lee KA; Bang SY; Park BL; Kim JH; Shin HD; Bae SC
Rheumatol Int; 2012 Jan; 32(1):91-6. PubMed ID: 20665026
[TBL] [Abstract][Full Text] [Related]
4. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
[TBL] [Abstract][Full Text] [Related]
5. NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia.
Cheong HS; Koh Y; Ahn KS; Lee C; Shin HD; Yoon SS
Pharmacogenet Genomics; 2014 Sep; 24(9):436-41. PubMed ID: 25000516
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.
Wang L; Cai W; Zhang W; Chen X; Dong W; Tang D; Zhang Y; Ji C; Zhang M
Oncotarget; 2015 Sep; 6(29):27490-504. PubMed ID: 26314963
[TBL] [Abstract][Full Text] [Related]
7. MCM7 polymorphisms associated with the AML relapse and overall survival.
Lee JS; Cheong HS; Koh Y; Ahn KS; Shin HD; Yoon SS
Ann Hematol; 2017 Jan; 96(1):93-98. PubMed ID: 27837251
[TBL] [Abstract][Full Text] [Related]
8. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
[TBL] [Abstract][Full Text] [Related]
10. Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia.
Chauhan PS; Ihsan R; Yadav DS; Mishra AK; Bhushan B; Soni A; Kaushal M; Devi TR; Saluja S; Gupta DK; Mittal V; Saxena S; Kapur S
DNA Cell Biol; 2011 Jan; 30(1):39-46. PubMed ID: 20731606
[TBL] [Abstract][Full Text] [Related]
11. Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia.
Mansour L; Alqahtani M; Aljuaimlani A; Al-Tamimi J; Al-Harbi N; Alomar S
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792904
[No Abstract] [Full Text] [Related]
12. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
[TBL] [Abstract][Full Text] [Related]
13. RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia.
Hamdy MS; El-Haddad AM; Bahaa El-Din NM; Makhlouf MM; Abdel-Hamid SM
J Investig Med; 2011 Oct; 59(7):1124-30. PubMed ID: 21725251
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between RAD51-G135C/XRCC3-C241T polymorphisms and development of acute myeloid leukemia with recurrent chromosome translocation].
Yang L; Liu L; Mi YC; Li JY; Ma XT; Ai XF; Qin TJ; Xu ZF; Wang JX; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):299-303. PubMed ID: 21729596
[TBL] [Abstract][Full Text] [Related]
15. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.
Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P
Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia.
Fischer M; Spies-Weisshart B; Schrenk K; Gruhn B; Wittig S; Glaser A; Hochhaus A; Scholl S; Schnetzke U
PLoS One; 2016; 11(3):e0150632. PubMed ID: 26963509
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and haplotypes of the CYP2B6 detoxification gene in the predisposition of Acute Myeloid Leukemia (AML) and induction of its cytogenetic abnormalities.
Daraki A; Kakosaiou K; Zachaki S; Sambani C; Aleporou-Marinou V; Kollia P; Manola KN
Cancer Genet; 2016 Nov; 209(11):525-533. PubMed ID: 27865701
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms in the CD44 gene and acute myeloid leukemia cancer risk in a Chinese population.
Wu H; Deng J; Zheng J; You Y; Li N; Li W; Wu D; Zhou Y
Mol Carcinog; 2015 Feb; 54(2):102-10. PubMed ID: 24038513
[TBL] [Abstract][Full Text] [Related]
19. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
20. Melanoma antigen encoding gene-A3 expression, its clinical significance, and its risk of developing acute myeloid leukemia.
Makhlouf MM
J Investig Med; 2011 Oct; 59(7):1131-6. PubMed ID: 21804405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
